Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
Recruiting · NCT06770842 · Registry updated 2025-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 2 | 2025-06-11 | NCT06770842 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Hong Kong | 349 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Medicine, Queen Mary Hospital | Hong Kong | Hong Kong | 5 |